The DOI matches its Crossref record; 7 of the 7 references it cites were found in a registry or an index.
High metabolic in vivo stability and bioavailability of a palmitoylated ghrelin receptor ligand assessed by mass spectrometry
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“On the other hand, our in vitro data demonstrate that similar to other neuropeptides [Kostelnik et al., 2015; Gros et al., 1990; Cianflone et al. 2003], TLQP-21 is rapidly degraded in plasma, leading to a number of fragments.”
From Clearance kinetics of the VGF-derived neuropeptide TLQP-21 (2018) · cites this paper as Kostelnik et al., 2015
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Addona, T. A., Abbatiello, S. E., Schilling, B., Skates, S. J., Mani, D. R., Bunk, D. M., Spiegelman, C. H., Zimmerman, L. J., Ham, A.-J. L., Keshishian, H., et al. (2009) · Nature Biotechnology · doi:10.1038/nbt.1546 · Cited by 1,037
Ghrelin Strongly Stimulates Growth Hormone Release in Humans
Takaya, K., Ariyasu, H., Kanamoto, N., Iwakura, H., Yoshimoto, A., Harada, M., Mori, K., Komatsu, Y., Usui, T., Shimatsu, A., et al. (2000) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.85.12.7167 · Cited by 864
Characteristics of Compounds that Cross the Blood-Brain Barrier
Banks, W. A. (2009) · BMC Neurology · doi:10.1186/1471-2377-9-s1-s3 · Cited by 710
High constitutive signaling of the ghrelin receptor–identification of a potent inverse agonist
Holst, B., Cygankiewicz, A., Jensen, T. H., Ankersen, M., & Schwartz, T. W. (2003) · Molecular Endocrinology · doi:10.1210/me.2003-0069 · Cited by 515
Hoofnagle, A. N., Becker, J. O., Oda, M. N., Cavigiolio, G., Mayer, P., & Vaisar, T. (2012) · Clinical Chemistry · doi:10.1373/clinchem.2011.173856 · Cited by 140
Peptide lipidation stabilizes structure to enhance biological function
Ward, B. P., Ottaway, N. L., Perez-Tilve, D., Ma, D., Gelfanov, V. M., Tschöp, M. H., & DiMarchi, R. D. (2013) · Molecular Metabolism · doi:10.1016/j.molmet.2013.08.008 · Cited by 101
Carvalho, V. M. (2012) · Journal of Chromatography B · doi:10.1016/j.jchromb.2011.08.027 · Cited by 90
Research works printed but not linked: 41
- Bellmann-Sickert, 2011, J. Med. Chem., 54, 2658, 10.1021/jm101357e · DOI
- Bellmann-Sickert, 2011, ChemMedChem, 6, 193, 10.1002/cmdc.201000403 · DOI
- Fani, 2012, Eur. J. Nucl. Med. Mol. Imaging, 39, S11, 10.1007/s00259-011-2001-z · DOI · Paper page
- Chollet, 2012, Bioconjug. Chem., 23, 771, 10.1021/bc2005889 · DOI
- Gevaert, 2008, Proteomics, 8, 4873, 10.1002/pmic.200800421 · DOI
- Nakamura, 2007, Biotechnol. Genet. Eng. Rev., 24, 147, 10.1080/02648725.2007.10648097 · DOI
- Yi, 2005, Proteomics, 5, 380, 10.1002/pmic.200400970 · DOI
- Yocum, 2009, Brief. Funct. Genomics, 8, 145, 10.1093/bfgp/eln056 · DOI
- Oertel, 2007, J. Chromatogr. A, 1149, 121, 10.1016/j.chroma.2006.11.021 · doi:10.1016/j.chroma.2006.11.021
- Lim, 2007, Rapid Commun. Mass Spectrom., 21, 1821, 10.1002/rcm.3024 · DOI
- Howard, 1996, Science, 273, 974, 10.1126/science.273.5277.974 · DOI · Paper page
- Kojima, 1999, Nature, 402, 656, 10.1038/45230 · DOI · Paper page
- Tschop, 2000, Nature, 407, 908, 10.1038/35038090 · DOI · Paper page
- Jerlhag, 2009, PNAS, Proc. Natl. Acad. Sci., 106, 11318, 10.1073/pnas.0812809106 · DOI · Paper page
- Li, 2013, Endocr. J., 60, 781, 10.1507/endocrj.EJ13-0008 · DOI
- Nikolopoulos, 2010, Regul. Pept., 163, 7, 10.1016/j.regpep.2010.03.011 · DOI
- Jeffery, 2002, J. Endocrinol., 172, R7, 10.1677/joe.0.172r007 · DOI · Paper page
- Gaytan, 2005, J. Clin. Endocrinol. Metab., 90, 1798, 10.1210/jc.2004-1532 · DOI
- Ahrens, 2012, Future Med. Chem., 4, 1567, 10.4155/fmc.12.76 · DOI
- Edwards, 1999, QJM, 92, 1, 10.1093/qjmed/92.1.1 · DOI
- Made, 2014, Beilstein J. Org. Chem., 10, 1197, 10.3762/bjoc.10.118 · DOI · Paper page
- Nestor, 2009, Curr. Med. Chem., 16, 4399, 10.2174/092986709789712907 · DOI
- Kurtzhals, 1995, Biochem. J., 312, 725, 10.1042/bj3120725 · DOI · Paper page
- Aicart-Ramos, 2011, Biochim. Biophys. Acta, 1808, 2981, 10.1016/j.bbamem.2011.07.009 · DOI · Paper page
- Zhang, 2012, Curr. Med. Chem., 19, 1602, 10.2174/092986712799945003 · DOI · Paper page
- Pasut, 2011, J. Control. Release, 161, 461, 10.1016/j.jconrel.2011.10.037 · DOI · Paper page
- Veronese, 2005, Drug Discovery Today, 10, 1451, 10.1016/S1359-6446(05)03575-0 · DOI · Paper page
- Rink, 2010, J. Pharmacol. Toxicol. Methods, 61, 210, 10.1016/j.vascn.2010.02.010 · DOI
- Hong, 1999, Biochem. Pharmacol., 58, 1775, 10.1016/S0006-2952(99)00259-2 · DOI · Paper page
- Els, 2012, J. Med. Chem., 55, 7437, 10.1021/jm300414b · DOI
- Els, 2010, Methods Enzymol., 485, 103, 10.1016/B978-0-12-381296-4.00006-3 · DOI
- Berridge, 1983, Biochem. J., 212, 849, 10.1042/bj2120849 · DOI · Paper page
- Berridge, 1983, Biochem. J., 212, 473, 10.1042/bj2120473 · DOI · Paper page
- Cheng, 2001, J. Pharmacol. Toxicol. Methods, 46, 61, 10.1016/S1056-8719(02)00166-1 · DOI · Paper page
- Holst, 2007, J. Biol. Chem., 282, 15799, 10.1074/jbc.M609796200 · DOI
- Mokrosinski, 2010, Methods Enzymol., 484, 53, 10.1016/B978-0-12-381298-8.00003-4 · DOI
- Holst, 2004, Trends Pharmacol. Sci., 25, 113, 10.1016/j.tips.2004.01.010 · DOI · Paper page
- McGregor, 2008, Curr. Opin. Pharmacol., 8, 616, 10.1016/j.coph.2008.06.002 · DOI · Paper page
- Guan, 1997, Brain Res. Mol. Brain Res., 48, 23, 10.1016/S0169-328X(97)00071-5 · DOI · Paper page
- Rousu, 2010, Rapid Commun. Mass Spectrom., 24, 939, 10.1002/rcm.4465 · DOI
- Hu, 2005, J. Mass Spectrom., 40, 430, 10.1002/jms.856 · DOI · Paper page
Cited by
Clearance kinetics of the VGF-derived neuropeptide TLQP-21
Guo, Z., Sahu, B. S., He, R., Finan, B., Cero, C., Verardi, R., Razzoli, M., Veglia, G., Di Marchi, R. D., Miles, J. M., et al. (2018) · Neuropeptides · doi:10.1016/j.npep.2018.06.003 · Cited by 21
Metadata
- Authors
- Kostelnik, K. B., Els-Heindl, S., Klöting, N., Baumann, S., von Bergen, M., & Beck-Sickinger, A. G.
- Venue
- Bioorganic & Medicinal Chemistry
- Publisher
- Elsevier BV
- Published
- 2015-07
- Volume
- 23
- Issue
- 14
- Pages
- 3925-3932
- ISSN
- 0968-0896
- Cited by
- 21
- References
- 7
- Language
- en
- Licence
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- www.elsevier.com/legal/tdmrep-license (tdm)
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.